Correlation Between Oncternal Therapeutics and Ikena Oncology
Can any of the company-specific risk be diversified away by investing in both Oncternal Therapeutics and Ikena Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncternal Therapeutics and Ikena Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncternal Therapeutics and Ikena Oncology, you can compare the effects of market volatilities on Oncternal Therapeutics and Ikena Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncternal Therapeutics with a short position of Ikena Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncternal Therapeutics and Ikena Oncology.
Diversification Opportunities for Oncternal Therapeutics and Ikena Oncology
0.09 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Oncternal and Ikena is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Oncternal Therapeutics and Ikena Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ikena Oncology and Oncternal Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncternal Therapeutics are associated (or correlated) with Ikena Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ikena Oncology has no effect on the direction of Oncternal Therapeutics i.e., Oncternal Therapeutics and Ikena Oncology go up and down completely randomly.
Pair Corralation between Oncternal Therapeutics and Ikena Oncology
Given the investment horizon of 90 days Oncternal Therapeutics is expected to under-perform the Ikena Oncology. In addition to that, Oncternal Therapeutics is 7.88 times more volatile than Ikena Oncology. It trades about -0.11 of its total potential returns per unit of risk. Ikena Oncology is currently generating about -0.08 per unit of volatility. If you would invest 185.00 in Ikena Oncology on August 25, 2024 and sell it today you would lose (14.00) from holding Ikena Oncology or give up 7.57% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Oncternal Therapeutics vs. Ikena Oncology
Performance |
| Timeline |
| Oncternal Therapeutics |
| Ikena Oncology |
Oncternal Therapeutics and Ikena Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oncternal Therapeutics and Ikena Oncology
The main advantage of trading using opposite Oncternal Therapeutics and Ikena Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncternal Therapeutics position performs unexpectedly, Ikena Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ikena Oncology will offset losses from the drop in Ikena Oncology's long position.| Oncternal Therapeutics vs. Eliem Therapeutics | Oncternal Therapeutics vs. HCW Biologics | Oncternal Therapeutics vs. RenovoRx | Oncternal Therapeutics vs. Tempest Therapeutics |
| Ikena Oncology vs. Eliem Therapeutics | Ikena Oncology vs. HCW Biologics | Ikena Oncology vs. RenovoRx | Ikena Oncology vs. Tempest Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |